As the accessibility of genetic testing expands, more people are exploring their own genetic code. And companies like 23andMe even offer tests that claim to identify increased genetic risk of breast, ovarian and other cancers. But it is crucial to understand the very real limitations of these direct-to-consumer tests and why it's important to keep a licensed healthcare provider in the loop.